Maria Camille Hoffman-shuler, MD - Medicare Obstetrics/gynecology in Aurora, CO

Maria Camille Hoffman-shuler, MD is a medicare enrolled "Obstetrics & Gynecology - Maternal & Fetal Medicine" physician in Aurora, Colorado. She went to Medical University Of South Carolina College Of Medicine and graduated in 2003 and has 21 years of diverse experience with area of expertise as Obstetrics/gynecology. She is a member of the group practice Scl Health Medical Group - Denver Llc, University Physicians Incorporated and her current practice location is 12605 E 16th Ave, Aurora, Colorado. You can reach out to her office (for appointments etc.) via phone at (720) 848-0000.

Maria Camille Hoffman-shuler is licensed to practice in Colorado (license number DR-45469) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1659493054.

Contact Information

Maria Camille Hoffman-shuler, MD
12605 E 16th Ave,
Aurora, CO 80045-2545
(720) 848-0000
Not Available



Physician's Profile

Full NameMaria Camille Hoffman-shuler
GenderFemale
SpecialityObstetrics/gynecology
Experience21 Years
Location12605 E 16th Ave, Aurora, Colorado
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Maria Camille Hoffman-shuler attended and graduated from Medical University Of South Carolina College Of Medicine in 2003
  NPI Data:
  • NPI Number: 1659493054
  • Provider Enumeration Date: 04/04/2007
  • Last Update Date: 05/15/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 8820287774
  • Enrollment ID: I20110107001034

Medical Identifiers

Medical identifiers for Maria Camille Hoffman-shuler such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1659493054NPI-NPPES
42852579MedicaidCO

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207VM0101XObstetrics & Gynecology - Maternal & Fetal Medicine DR-45469 (Colorado)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Scl Health Medical Group - Denver Llc0840513552414
University Physicians Incorporated34764656672657

News Archive

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Researchers from Massachusetts Eye and Ear/Harvard Medical School have conducted a clinical trial comparing the safety and efficacy of topical tacrolimus, an immunosuppressive therapy, and topical methylprednisolone, a steroid medication, in patients with ocular graft-versus-host-disease (GVHD) - a complication associated with allogeneic bone marrow transplants in which the transplanted immune system's cells attack certain parts of the recipient's body, including the cornea and ocular surface.

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

A new study reported that zolpidem, a drug normally used to treat insomnia, temporarily improved brain function in a patient suffering from akinetic mutism, a condition in which the person is alert but cannot speak or move.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Two 2008 drug approval reports highlight Ceplene benefits

EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Maria Camille Hoffman-shuler allows following entities to bill medicare on her behalf.
Entity NameUniversity Physicians Incorporated
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1962461889
PECOS PAC ID: 3476465667
Enrollment ID: O20031105000375

News Archive

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Researchers from Massachusetts Eye and Ear/Harvard Medical School have conducted a clinical trial comparing the safety and efficacy of topical tacrolimus, an immunosuppressive therapy, and topical methylprednisolone, a steroid medication, in patients with ocular graft-versus-host-disease (GVHD) - a complication associated with allogeneic bone marrow transplants in which the transplanted immune system's cells attack certain parts of the recipient's body, including the cornea and ocular surface.

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

A new study reported that zolpidem, a drug normally used to treat insomnia, temporarily improved brain function in a patient suffering from akinetic mutism, a condition in which the person is alert but cannot speak or move.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Two 2008 drug approval reports highlight Ceplene benefits

EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.

Read more Medical News

› Verified 7 days ago

Entity NameCatholic Health Initiatives Colorado
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1356783351
PECOS PAC ID: 8022927342
Enrollment ID: O20031215000462

News Archive

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Researchers from Massachusetts Eye and Ear/Harvard Medical School have conducted a clinical trial comparing the safety and efficacy of topical tacrolimus, an immunosuppressive therapy, and topical methylprednisolone, a steroid medication, in patients with ocular graft-versus-host-disease (GVHD) - a complication associated with allogeneic bone marrow transplants in which the transplanted immune system's cells attack certain parts of the recipient's body, including the cornea and ocular surface.

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

A new study reported that zolpidem, a drug normally used to treat insomnia, temporarily improved brain function in a patient suffering from akinetic mutism, a condition in which the person is alert but cannot speak or move.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Two 2008 drug approval reports highlight Ceplene benefits

EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.

Read more Medical News

› Verified 7 days ago

Entity NameSaint Joseph Hospital, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154361350
PECOS PAC ID: 6204735970
Enrollment ID: O20040102000258

News Archive

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Researchers from Massachusetts Eye and Ear/Harvard Medical School have conducted a clinical trial comparing the safety and efficacy of topical tacrolimus, an immunosuppressive therapy, and topical methylprednisolone, a steroid medication, in patients with ocular graft-versus-host-disease (GVHD) - a complication associated with allogeneic bone marrow transplants in which the transplanted immune system's cells attack certain parts of the recipient's body, including the cornea and ocular surface.

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

A new study reported that zolpidem, a drug normally used to treat insomnia, temporarily improved brain function in a patient suffering from akinetic mutism, a condition in which the person is alert but cannot speak or move.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Two 2008 drug approval reports highlight Ceplene benefits

EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.

Read more Medical News

› Verified 7 days ago

Entity NameScl Health Front Range Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649210188
PECOS PAC ID: 6800799537
Enrollment ID: O20040130000049

News Archive

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Researchers from Massachusetts Eye and Ear/Harvard Medical School have conducted a clinical trial comparing the safety and efficacy of topical tacrolimus, an immunosuppressive therapy, and topical methylprednisolone, a steroid medication, in patients with ocular graft-versus-host-disease (GVHD) - a complication associated with allogeneic bone marrow transplants in which the transplanted immune system's cells attack certain parts of the recipient's body, including the cornea and ocular surface.

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

A new study reported that zolpidem, a drug normally used to treat insomnia, temporarily improved brain function in a patient suffering from akinetic mutism, a condition in which the person is alert but cannot speak or move.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Two 2008 drug approval reports highlight Ceplene benefits

EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.

Read more Medical News

› Verified 7 days ago

Entity NameScl Health Medical Group - Denver Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1083021083
PECOS PAC ID: 0840513552
Enrollment ID: O20150106000131

News Archive

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Researchers from Massachusetts Eye and Ear/Harvard Medical School have conducted a clinical trial comparing the safety and efficacy of topical tacrolimus, an immunosuppressive therapy, and topical methylprednisolone, a steroid medication, in patients with ocular graft-versus-host-disease (GVHD) - a complication associated with allogeneic bone marrow transplants in which the transplanted immune system's cells attack certain parts of the recipient's body, including the cornea and ocular surface.

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

A new study reported that zolpidem, a drug normally used to treat insomnia, temporarily improved brain function in a patient suffering from akinetic mutism, a condition in which the person is alert but cannot speak or move.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Two 2008 drug approval reports highlight Ceplene benefits

EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Maria Camille Hoffman-shuler is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Maria Camille Hoffman-shuler, MD
3655 Lutheran Pkwy, Suite 408,
Wheat Ridge, CO 80033-6018

Ph: (303) 467-4282
Maria Camille Hoffman-shuler, MD
12605 E 16th Ave,
Aurora, CO 80045-2545

Ph: (720) 848-0000

News Archive

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Researchers from Massachusetts Eye and Ear/Harvard Medical School have conducted a clinical trial comparing the safety and efficacy of topical tacrolimus, an immunosuppressive therapy, and topical methylprednisolone, a steroid medication, in patients with ocular graft-versus-host-disease (GVHD) - a complication associated with allogeneic bone marrow transplants in which the transplanted immune system's cells attack certain parts of the recipient's body, including the cornea and ocular surface.

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

A new study reported that zolpidem, a drug normally used to treat insomnia, temporarily improved brain function in a patient suffering from akinetic mutism, a condition in which the person is alert but cannot speak or move.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Two 2008 drug approval reports highlight Ceplene benefits

EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.

Read more News

› Verified 7 days ago


Obstetrics & Gynecology Doctors in Aurora, CO

Catherine Elizabeth Callinan, MD
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 1635 Aurora Ct, Aurora, CO 80045
Phone: 720-848-0000    
Christianne Persenaire, M.D.
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 1665 Aurora Ct Fl 2, Aurora, CO 80045
Phone: 303-724-2066    Fax: 303-724-2053
Kian Behbakht, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 12605 E 16th Ave, Aurora, CO 80045
Phone: 720-848-0000    
Amanda Jean Johnson, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 12605 E 16th Ave, Aurora, CO 80045
Phone: 720-848-0000    
Ivy L Lersten, M.D.
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 13001 E 17th Pl, Aurora, CO 80045
Phone: 303-724-2052    Fax: 303-724-2055
Nicholas Behrendt, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 12605 E 16th Ave, Aurora, CO 80045
Phone: 720-848-0000    
Sz-min Harley, MD
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 1400 S Potomac St, #220, Aurora, CO 80012
Phone: 303-690-2198    Fax: 303-369-1807

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.